Breaking down barriers
The UK Centre for Medical Research and Innovation has been described as one of the most significant developments in biomedical research for a generation. Here two of the project’s leading scientis ...
|
Waiting for the great leap forward
Is clinical research in the UK on the verge of extinction? Peter Mansell looks at the arguments around whether the industry is able to take that necessary leap forward
|
Lessons from an investigator-led trial
Dr Andreas Goebel talks candidly about the barriers he encountered in preparing a multicentre trigeminal neuralgia trial in the UK, and offers some of the learnings that could help inform both inv ...
|
Government launches first Therapeutic Capability Clusters
The Conservative-Liberal Democrat coalition has launched the first of the UK’s Therapeutic Capability Clusters, a research partnership initiative originally unveiled by the Office for Life Science ...
|
ReNeuron’s PISCES stem cell trial underway in Scot-land
A Phase I clinical trial of ReN001, ReNeuron’s stem cell therapy for patients left disabled by ischaemic stroke, is underway in Scotland, where the first patient has been treated at the Institute ...
|
ICON pharmacology unit awarded ?MHRA Supplementary Accreditation
A Clinical Pharmacology Unit run in Manchester by ICON, the global provider of outsourced development services based in Ireland, has achieved Supplementary Accreditation status following an inspec ...
|
New version of IRAS includes EudraCT Annex 2 form
An updated version of IRAS, the Integrated Research Application System launched by the UK Clinical Research Collaboration (UKCRC) in January 2008, is now available for use.
|
Venture capitalists name Synexus’ Fort CEO of the year
Michael Fort, chief executive officer of UK-based patient recruitment and clinical trial management business Synexus, was named CEO of the Year at the finals of the British Venture Capital Associa ...
|
Roslin launches cell therapy partner programme
A partner programme offering commercial and academic researchers access both to Good Manufacturing Practice-level stem cells and to expertise in translating their research into cell therapies has ...
|
NRES launches toolkit for research with adults lacking capacity
The National Research Ethics Service (NRES), the umbrella body for ethics committees in the NHS, has launched an online toolkit on research involving adults who lack the capacity to provide inform ...
|
Almac gets MHRA all-clear for clinical services site
The Almac Group, whose operations range from R&D to manufacturing, formulation development and clinical trial supplies, has undergone a successful MHRA inspection of its Clinical Services UK facil ...
|
Two business leader awards for ClinTec CEO Buttar
Dr Rabinder Buttar, chief executive officer and president of UK-based contract research organisation ClinTec International, was recently named Business Woman of the Year at the Sikh Awards in London.
|
Collaborative development is way forward for biotech industry
The biotechnology industry needs to embrace strategic collaboration more readily to ensure its survival, a new research paper from consultants PricewaterhouseCoopers (PwC) argues.
|
One in six UK cancer patients now in clinical trials
Around one in six patients diagnosed with cancer in the UK now take part in clinical trials, compared with one in every 26 patients a decade ago.
|
More intensive statin therapy further improves cardiovascular outcomes
More aggressive treatment with cholesterol-lowering statins can cut the risk of major vascular events such as heart attack by an additional 15%, a meta-analysis by researchers in the UK and Austra ...
|
Genetic switch discovered that turns on pain
Aberdeen scientists have discovered a ‘switch’ that turns on a gene that lets us feel pain, in a finding that could be a step towards the development of new painkilling drugs.
|
Academy of Medical Sciences report
The Academy of Medical Sciences (AMS) releases its report which recommends urgent changes to the regulation and governance of health research in the UK.
|
CANCER RESEARCH UK AND ASTRAZENECA COLLABORATE TO TRIAL COMBINATIONS OF NEW CANCER DRUGS
CANCER RESEARCH UK’s drug development office (DDO) has signed a Strategic Combinations Alliance with AstraZeneca to take combinations of experimental cancer drugs into early phase clinical trials.
|
SCIENTISTS DISCOVER FIRST BREAST CANCER ‘ONCOGENE’ FOR FIVE YEARS
CANCER RESEARCH UK scientists have pinpointed a key cancer-causing gene that, when overactive, triggers a particularly aggressive type of breast cancer to develop.
|
AstraZeneca investing $150 million on a manufacturing facility in Russia
In a move to side step the possible block of imported medicines AstraZeneca has announced it is constructing a manufacturing facility in Russia.
|